News & Updates
Filter by Specialty:
Lung nodule surveillance programme helps detect early-stage lung cancer
A lung nodule surveillance programme at Queen Mary Hospital (QMH) facilitates diagnosis of early-stage lung cancer. Data from the programme’s first year of implementation showed a higher proportion of early-stage lung cancer diagnoses compared with the Hong Kong Cancer Registry’s (HKCR) annual report.
Lung nodule surveillance programme helps detect early-stage lung cancer
22 Aug 2025
Sotatercept: A first-in-class PAH medication approved in HK
Sotatercept, a first-in-class acÂtivin signalling inhibitor for pulÂmonary arterial hypertension (PAH), is approved in Hong Kong in August 2025, following regulatory apÂprovals in Macau, the US, and the EU in February 2025.
Sotatercept: A first-in-class PAH medication approved in HK
20 Aug 2025
Real-world data: FF/UMEC/VI offers clinical advantages over another 3-in-1 COPD inhaler
Once-daily, single-inhaler triple therapy with fluticasone fuÂroate/umeclidinium/vilanterÂol (FF/UMEC/VI) outperforms twice-daily, single-inhaler triple therapy with budesonide/glycopyrrolate/forÂmoterol fumarate (BUD/GLY/ FORM) in the treatment of chronÂic obstructive pulmonary disease (COPD), two recent real-world comparative effectiveness studies have found.
